Estrogen and Progesterone Receptors in the Endometrium of Postmenopausal Breast Cancer Patients Treated with Tamoxifen and Progestogens

By Cohen I.   Altaras M.M.   Beyth Y.   Shapira J.   Figer A.   Tepper R.   Cordoba M.   Yigal D.   Bernheim J.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 83-88

Elsevier

Access to resources Recommend Favorite

Long-Term Transvaginal Ultrasonographic Endometrial Follow-up in Postmenopausal Breast Cancer Patients with Tamoxifen Treatment

By Nahari C.   Tepper R.   Beyth Y.   Flex D.   Figer A.   Cohen I.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

By Rutqvist Lars   Johansson Hemming   Group on behalf of the Stockholm Breast Cancer Study  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 133-145

Informa Healthcare

Access to resources Recommend Favorite

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

By Rydén Lisa  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and Progesterone Receptor Expression in Postmenopausal Tamoxifen-Exposed Endometrial Pathologies

By Cohen I.   Beyth Y.   Altaras M.M.   Shapira J.   Tepper R.   Cardoba M.   Yigael D.   Figer A.   Fishman A.   Berenhein J.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 8-15

Elsevier

Access to resources Recommend Favorite